Daily Brief Health Care: Sunmax Biotechnology, Sunway Healthcare, Eco Animal Health, Medikit Co Ltd and more

• Sunmax is a niche leader in collagen-based dermal fillers, capitalizing on a rapidly growing global medical aesthetics market driven by non-invasive procedures.
• The company exhibits a strong growth trajectory, evidenced by impressive multi-year CAGRs in revenue and net income, supported by high resilience and profitability metrics.
• Future growth is contingent on successful capacity expansion, with a new facility expected to be fully operational by H1 2027, and continued geographic expansion beyond its core markets in Taiwan and China.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Sunway Healthcare is a leading integrated private healthcare provider in Malaysia with ambitious expansion plans, aiming to significantly increase its bed capacity and network of hospitals across the country, positioning it to capitalize on the growing demand for quality healthcare in the region.
• The upcoming Initial Public Offering (IPO), expected by the first quarter of 2026, is a significant catalyst, intended to raise substantial capital to fund its aggressive growth strategy, including the development of new hospitals and the expansion of ancillary healthcare services.
• The company benefits from strong parentage under the Sunway Group conglomerate and a strategic partnership with Singapore’s sovereign wealth fund, GIC, which provides financial backing and regional healthcare expertise, enhancing its growth prospects and market credibility.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Centaur Media 41p £60.4m (CAU.L) The international provider of business intelligence, learning and specialist consultancy has announced that the group has signed an unconditional sale and purchase agreement with Haymarket Media Group Limited for the sale of MWCR Limited, being the operating company of Marketing Week, Festival of Marketing and Creative Review, for an enterprise value of £3.9m.
• The consideration for the Transaction is £3.9m, will be received in cash later today. The Transaction follows the sale of MiniMBA by the Group which completed on 18 July 2025 and the sale of The Lawyer announced on 11 September 2025.
• The disposals are a consequence of the announcement on 12 December 2024 stating that, led by Martin Rowland, Executive Chair, the Board were to review Centaur’s business operations and strategy and to maximise shareholder value.

• Medikit is a specialized Japanese manufacturer of vascular access devices, holding a strong domestic market position in core products like intravenous (IV) catheters and hemodialysis catheters.
• The company is poised to benefit from stable, non-discretionary demand driven by Japan’s aging population and the rising prevalence of chronic kidney disease, which necessitates dialysis.
• Despite a solid dividend track record and attractive valuation multiples relative to peers, Medikit faces challenges from sluggish revenue growth, negative free cash flow in recent years, and increasing competition in a technologically advancing global market.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.